Show simple item record

dc.creatorGerlinger, C.en
dc.creatorEdler, L.en
dc.creatorFriede, T.en
dc.creatorKieser, M.en
dc.creatorNakas, C. T.en
dc.creatorSchumacher, M.en
dc.creatorSeldrup, J.en
dc.creatorVictor, N.en
dc.date.accessioned2015-11-23T10:27:45Z
dc.date.available2015-11-23T10:27:45Z
dc.date.issued2012
dc.identifier10.1002/sim.4345
dc.identifier.issn0277-6715
dc.identifier.urihttp://hdl.handle.net/11615/27791
dc.description.abstractInternational regulatory guidelines require that a qualified statistician takes responsibility for the statistical aspects of a clinical trial used for drug licensing. No consensus on what constitutes a qualified statistician appears to have been developed so far. The International Society for Clinical Biostatistics is issuing this reflection paper in order to stimulate a discussion on the concept. Copyright (C) 2011 John Wiley & Sons, Ltd.en
dc.sourceStatistics in Medicineen
dc.source.uri<Go to ISI>://WOS:000304088900025
dc.subjectqualified statisticianen
dc.subjectregulatory affairsen
dc.subjectICHen
dc.subjectguidelineen
dc.subjectMathematical & Computational Biologyen
dc.subjectPublic, Environmental &en
dc.subjectOccupational Healthen
dc.subjectMedical Informaticsen
dc.subjectMedicine, Research &en
dc.subjectExperimentalen
dc.subjectStatistics & Probabilityen
dc.titleConsiderations on what constitutes a 'qualified statistician' in regulatory guidelinesen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record